Atsushi Kumanogoh

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 443 publications

Migration-dependent extrafollicular programming of pre-plasmablast age-associated B cells drives lupus pathogenesis.

Migration-dependent extrafollicular programming of pre-plasmablast age-associated B cells drives lupus pathogenesis.

Journal: The Journal of clinical investigation

Published: July 14, 2026

Mycobacterium brisbanense Pulmonary Disease Treated with a Macrolide-Based Multidrug Regimen: A Case Report.

Mycobacterium brisbanense Pulmonary Disease Treated with a Macrolide-Based Multidrug Regimen: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: June 10, 2026

Immunopathophysiology of immune checkpoint inhibitor-related pneumonitis: insights from multi-omics and immune profiling.

Immunopathophysiology of immune checkpoint inhibitor-related pneumonitis: insights from multi-omics and immune profiling.

Journal: Immunological medicine

Published: May 18, 2026

Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer.

Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 08, 2026

Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: The ANSWER cohort study.

Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: The ANSWER cohort study.

Journal: Joint bone spine

Published: March 26, 2026

Comparison of Long-Term Survival Between Nivolumab Plus Ipilimumab and Nivolumab Plus Ipilimumab With Chemotherapy in Advanced NSCLC: A Multicenter Retrospective Cohort Study.

Comparison of Long-Term Survival Between Nivolumab Plus Ipilimumab and Nivolumab Plus Ipilimumab With Chemotherapy in Advanced NSCLC: A Multicenter Retrospective Cohort Study.

Journal: JTO clinical and research reports

Published: March 24, 2026

Granulocyte heterogeneity in immune-mediated and inflammatory diseases: Insights from single-cell transcriptomic analyses.

Granulocyte heterogeneity in immune-mediated and inflammatory diseases: Insights from single-cell transcriptomic analyses.

Journal: International immunology

Published: March 24, 2026

Late-Onset Acute Cellular Rejection after Lung Transplantation Triggered by a Fluctuation in the Tacrolimus Trough Level Which Was Successfully Treated with Steroid Pulse Therapy.

Late-Onset Acute Cellular Rejection after Lung Transplantation Triggered by a Fluctuation in the Tacrolimus Trough Level Which Was Successfully Treated with Steroid Pulse Therapy.

Journal: Internal medicine (Tokyo, Japan)

Published: March 18, 2026

Developing immunotherapies through glycosylation reprogramming to combat solid cancers.

Developing immunotherapies through glycosylation reprogramming to combat solid cancers.

Journal: Frontiers in immunology

Published: March 06, 2026

Thymic cyst: A clinicopathological, immunohistochemical, and molecular study of 36 cases focusing on squamous- and ciliated-type epithelium.

Thymic cyst: A clinicopathological, immunohistochemical, and molecular study of 36 cases focusing on squamous- and ciliated-type epithelium.

Journal: Human pathology

Published: March 04, 2026

Comparison of culture and culture-free methods for comprehensive identification of mycobacteria: a single-center prospective study.

Comparison of culture and culture-free methods for comprehensive identification of mycobacteria: a single-center prospective study.

Journal: Journal of clinical microbiology

Published: February 27, 2026

Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort.

Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort.

Journal: Clinical rheumatology

Published: February 12, 2026

Showing 1-12 of 443

Last Updated: 09/26/2026